Abstract
BackgroundA subset of patients with connective tissue disease associated interstitial lung disease (CTD-ILD) progresses. These patients have been included in clinical ILD trials as a group despite their different underlying...
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have